Home › Bulimia Nervosa › NCT07581158
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa Via a Combined Real-Time Neurofeedback and Smartphone Intervention
Who can join
Ages 18 to 55 · Women
Full eligibility criteria
Inclusion criteria: * Female * Aged 18 to 55 years * Meet diagnostic criteria for bulimia nervosa (BN) or BN of low frequency and/or limited duration * Current body mass index greater than or equal to 18.5kg/m2 but under 40kg/m2 * English-speaking Exclusion criteria: * Ongoing medical treatment or planned/recent change in medical treatment, major medical condition, or psychiatric disorder that may interfere with study variables or participation * Current psychotherapy focused primarily on eating disorder symptoms * Pregnancy or planned pregnancy, or lactation during the study period * Allergy to ingredients in the shake
About the study
The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using wearable brain imaging, functional near-infrared spectroscopy (fNIRS), together with a brain-based 4-week text-messaging intervention. The investigators will examine how these interventions may influence inhibitory control and eating disorder symptoms in women with bulimia nervosa.
What is being tested
- Real fNIRS Neurofeedback (other)
- Sham-Control fNIRS Neurofeedback (other)
- SmartPhone Intervention (other)
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 40 · Started: Jun 17, 2026
Contact the study team
- Sila Sozeri, B.A. · Phone: (212) 201-2679
Official record on ClinicalTrials.gov — NCT07581158
Locations in the U.S.
| New York | Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai, New York |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.